LURASIDONE HYDROCHLORIDE (lurasidone hydrochloride) by Jubilant Therapeutics is 12. Approved for adolescent patients (13 to 17 years) with schizophrenia [see clinical studies ()], schizophrenia, depression and 1 more indications. First approved in 2019.
Drug data last refreshed 18h ago
12.1 Mechanism of Action The mechanism of action of lurasidone in the treatment of schizophrenia and bipolar depression is unclear. However, its efficacy in schizophrenia and bipolar depression could be mediated through a combination of central dopamine D 2 and serotonin Type 2 (5HT 2A ) receptor…
Worked on LURASIDONE HYDROCHLORIDE at Jubilant Therapeutics? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.